Leo Lithium Limited

LLL

Leo Lithium Ltd. engages in the provision of exploration and development of the Goulamina Lithium Project. The company is headquartered in Perth, Western Australia. The company went IPO on 2022-06-23. The firm is focused on the development of the Goulamina lithium project in Mali in a joint venture with Ganfeng Lithium Co. Ltd. The Goulamina Lithium project comprises a land holding of approximately 100 square kilometers (km2) in the Bougouni Region of southern Mali, approximately 150 kilometers (km) by road from Mali's capital, Bamako. The land holding comprises of Goulamina mineral deposit.

Firefinch Limited

FFX

Firefinch Ltd. Is a mineral exploration company, which engages in mining of gold and mineral properties. The company is headquartered in Leederville, Western Australia. The firm is engaged in the exploration, development, and production of mineral assets in Mali, chiefly lithium and gold. Its projects includes Tujuh Bukit gold-copper-silver project in Indonesia, Sundance Resources Limited's (Sundance) iron mine in Burkina Faso and the Kumba Iron Project in Western Australia.

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the provision of exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm owns 100% of an independent hard-rock lithium operation, the Pilgangoora operation in Australia, and the Colina Project in Brazil. Its Pilgangoora operation is located 140 kilometers (kms) from Port Hedland in Western Australia’s resource rich Pilbara region on Nyamal and Kariyarra Country. Spodumene concentrate from its Pilgangoora operation is shipped from Port Hedland, the bulk export port, to lithium chemical converters primarily in China. The firm's Colina project is located 10 kms from the town of Salinas in the world class mining jurisdiction of Minas Gerais, Brazil. The firm is also integrated into the lithium value chain through its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Betashares Australia 200 ETF

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 8203.28m in AUM and 199 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.